TABLE 2.
Strain | IC50 (nM)* |
A/KANAGAWA/ZC1802/2018 (H1N1pdm09) | 32.1 ± 5.0 |
A/KANAGAWA/AC1877/2019 (H3N2) | 23.6 ± 11.2 |
B/KANAGAWA/AC1807/2019 (Victoria) | 60.0 ± 49.2 |
B/KANAGAWA/IC1740/2018 (Yamagata) | 47.8 ± 19.9 |
*The half-maximal inhibitory concentration (IC50) was determined from the result of the plaque assay. Average values with standard deviations from three independent experiments were shown.